Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts; Institute for Technology Assessment, Massachusetts General Hospital, Boston, Massachusetts.
Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts.
J Am Coll Radiol. 2018 Nov;15(11):1565-1572. doi: 10.1016/j.jacr.2018.03.001. Epub 2018 Apr 21.
Our goal is to define patient navigation for an imaging audience, present a focused selection of published experiences with navigation programs for breast and colorectal cancer screening, and expose principal barriers to the success of such programs. Despite numerous advances in the early detection of cancers, many patients still present with advanced disease. A disproportionate number are low-income minority patients who experience worse health outcomes than their white or more financially stable counterparts. Patient navigation, which aims to assist the medically underserved by overcoming specific barriers to care, may represent one solution to narrowing disparities. Related research suggests that in general, patient navigation programs that have addressed breast or colorectal cancer screening have been successful in improving screening rates and timeliness of follow-up care. However, although beneficial, navigation is expensive and may present an unmanageable financial burden for many health care centers. To overcome this challenge, navigation efforts will likely need to target those patients that are most likely to benefit. Further research to identify such patients will be critically important for improving the sustainability of navigation programs, and, in turn, for realizing the benefits of such programs in reducing cancer disparities.
我们的目标是为影像受众定义患者导航,呈现针对乳腺癌和结直肠癌筛查的导航计划的精选经验,并揭示此类计划成功的主要障碍。尽管癌症的早期检测取得了许多进展,但仍有许多患者出现晚期疾病。相当多的患者是低收入少数民族患者,他们的健康状况比白人或经济状况更稳定的患者差。患者导航旨在通过克服医疗服务不足者获得医疗服务的特定障碍来帮助他们,可能是缩小差距的一种解决方案。相关研究表明,一般来说,针对乳腺癌或结直肠癌筛查的患者导航计划已经成功地提高了筛查率和后续护理的及时性。然而,尽管有益,但导航费用昂贵,可能对许多医疗中心造成不可承受的经济负担。为了克服这一挑战,导航工作可能需要针对最有可能受益的患者。进一步的研究来确定这些患者将对提高导航计划的可持续性至关重要,从而实现这些计划在减少癌症差异方面的益处。